Alerts will be sent to your verified email
Verify Email
None
|
Agilus Diagnostics
|
Ajanta Pharma
|
Dr. Reddy's Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.76 % | 21.63 % | 15.68 % |
|
5yr average Equity Multiplier
|
1.31 | 1.32 | 1.41 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.84 | 0.74 |
|
5yr Avg Net Profit Margin
|
13.54 % | 19.77 % | 15.18 % |
|
Price to Book
|
n/a | 8.09 | 2.82 |
|
P/E
|
n/a | 34.42 | 18.25 |
|
5yr Avg Cash Conversion Cycle
|
-76.03 Days | -102.34 Days | 74.48 Days |
|
Inventory Days
|
12.61 Days | 55.16 Days | 76.14 Days |
|
Days Receivable
|
40.18 Days | 49.8 Days | 95.44 Days |
|
Days Payable
|
133.32 Days | 195.69 Days | 102.6 Days |
|
5yr Average Interest Coverage Ratio
|
16.11 | 108.5 | 35.66 |
|
5yr Avg ROCE
|
8.69 % | 27.48 % | 21.82 % |
|
5yr Avg Operating Profit Margin
|
18.66 % | 27.65 % | 23.61 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.12 |
|
5yr CAGR Net Profit
|
-5.76 % | 7.08 % | 23.71 % |
|
5yr Average Return on Assets
|
7.77 % | 16.51 % | 11.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 66.25 % | 26.64 % |
|
Share Pledged by Promoters
|
n/a | 17.29 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | 0.14 % | -0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 1.92 % | 2.93 % |
|
Agilus Diagnostics
|
Ajanta Pharma
|
Dr. Reddy's Lab
|
|---|